Peachey N S, Green D J, Ripps H
Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago College of Medicine 60612.
Invest Ophthalmol Vis Sci. 1993 Jan;34(1):58-65.
This study sought to examine the acute effects of ocular ischemia and reperfusion on retinal function and determine the extent to which recovery during reperfusion is improved by allopurinol (AP), a blocker of xanthine oxidase (XO). The latter is presumed to be a major factor in the formation of free radicals associated with reperfusion of ischemic tissue.
Electroretinographic (ERG) responses were recorded simultaneously from the two isolated, arterially perfused eyes obtained from the same cat. One eye served as the control and received only the standard perfusate; the other eye was infused with AP before and after a 3 hr period of total ischemia.
After the prolonged period of nonperfusion, recovery of the electroretinographic components was incomplete to varying degrees. Maximum b-wave amplitudes recovered only to 17 +/- 5% (mean +/- SEM) of baseline, whereas the a-wave grew to 60 +/- 10% of its baseline value. For both measures, the recovery of electroretinographic amplitude was significantly greater in AP-treated eyes than in the control eyes.
Generation of free radicals by XO contributes to the retinal damage and loss of function that occurs after a period of ischemia and subsequent reperfusion.
本研究旨在探讨眼部缺血及再灌注对视网膜功能的急性影响,并确定黄嘌呤氧化酶(XO)阻滞剂别嘌呤醇(AP)能在多大程度上改善再灌注期间的恢复情况。XO被认为是与缺血组织再灌注相关的自由基形成的主要因素。
从同一只猫获取的两只分离的、动脉灌注的眼睛同时记录视网膜电图(ERG)反应。一只眼睛作为对照,仅接受标准灌注液;另一只眼睛在完全缺血3小时前后输注AP。
在长时间无灌注后,视网膜电图各成分的恢复程度各不相同且不完全。最大b波振幅仅恢复至基线的17±5%(平均值±标准误),而a波增长至其基线值的60±10%。对于这两项指标,AP处理组眼睛的视网膜电图振幅恢复均显著高于对照组眼睛。
XO产生的自由基导致缺血及随后再灌注后发生的视网膜损伤和功能丧失。